Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the clinical response rate of local steroids in the treatment of
idiopathic granulomatous mastitis in female adults. Half of the participants will receive
local injection combined with topical steroids and the other half will receive topical
steroids mono-therapy.